-
The associations between modifiable risk factors and nonalcoholic fatty liver disease: A comprehensive Mendelian randomization study Hepatology (IF 17.298) Pub Date : 2022-08-16 Jiarong Xie, Hangkai Huang, Zhening Liu, Youming Li, Chaohui Yu, Lei Xu, Chengfu Xu
Early identification of modifiable risk factors is essential for the prevention of NAFLD. We aimed to systematically explore the relationships between genetically predicted modifiable risk factors and nonalcoholic fatty liver disease (NAFLD).
-
Mitochondrial stress in advanced fibrosis and cirrhosis associated with chronic hepatitis B, chronic hepatitis C or nonalcoholic steatohepatitis Hepatology (IF 17.298) Pub Date : 2022-08-16 Dimitri Loureiro, Issam Tout, Stéphanie Narguet, Cheikh Mohamed Bed, Morgane Roinard, Ahmad Sleiman, Nathalie Boyer, Nathalie Pons-Kerjean, Corinne Castelnau, Nathalie Giuly, Dorothy Tonui, Vassili Soumelis, Jamel El Benna, Patrick Soussan, Richard Moreau, Valérie Paradis, Abdellah Mansouri, Tarik Asselah
Hepatitis B virus infection causes oxidative stress and alters mitochondria in experimental models. Our goal was to investigate if HBV might alter liver mitochondria also in human, and the resulting mitochondrial stress might account for the progression of fibrosis in chronic hepatitis B (CHB).
-
Clinical Trials in HDV: Measuring Success Hepatology (IF 17.298) Pub Date : 2022-08-15 Ben L. Da
Chronic hepatitis D infection results in the most severe form of chronic viral hepatitis but currently lacks effective treatment options. Therapy with pegylated interferon alpha (PEG-IFNα) is recommended for finite treatment duration by major liver societies. Still, it is plagued by low rates of sustained virologic response (SVR) and frequent relapses even if SVR is achieved. Recently, a wave of new
-
Modeling Liver Hereditary Hemorrhagic Telangiectasia with Right Heart Overload to the Core of Liver Sinusoidal Endothelial Cells. Hepatology (IF 17.298) Pub Date : 2022-08-15 Orlando Musso
-
Intrahepatic paracrine signaling by CLCF1 ameliorates diet-induced NASH in mice Hepatology (IF 17.298) Pub Date : 2022-08-11 Tongyu Liu, Qiuyu Wang, Linkang Zhou, Peng Zhang, Lin Mi, Xiaoxue Qiu, Zhimin Chen, Henry Kuang, Siming Li, Jiandie D. Lin
The mammalian liver harbors heterogeneous cell types that communicate via local paracrine signaling. Recent studies have delineated the transcriptomic landscape of the liver in nonalcoholic steatohepatitis (NASH) that provides insights into liver cell heterogeneity, intercellular crosstalk, and disease-associated reprogramming. However, the nature of intrahepatic signaling and its role in NASH progression
-
Fibroblasts to hepatocytes: a non-stop flight into cell therapy for liver diseases? Hepatology (IF 17.298) Pub Date : 2022-08-11 Valerie Gouon-Evans,Romina Fiorotto
-
Profiling of murine syngeneic HCC tumor models as a framework to understand anti-PD-1 sensitive tumor microenvironments Hepatology (IF 17.298) Pub Date : 2022-08-08 Daniel J. Zabransky, Ludmila Danilova, James M. Leatherman, Tamara Y. Lopez-Vidal, Jessica Sanchez, Soren Charmsaz, Nicole E. Gross, Sarah Shin, Xuan Yuan, Alexei Hernandez, Hongqui Yang, Stephanie Xavier, Daniel Shu, Ali Saeed, Kabeer Munjal, Zeal Kamdar, Luciane T. Kagohara, Elizabeth M. Jaffee, Mark Yarchoan, Won Jin Ho
The treatment of hepatocellular carcinoma (HCC) has been transformed by the use of immune checkpoint inhibitors. However, most patients with HCC do not benefit from treatment with immunotherapy. There is an urgent need to understand the mechanisms that underlie response or resistance to immunotherapy for patients with HCC. The use of syngeneic mouse models that closely recapitulate the heterogeneity
-
TIGIT blockade elicits potent anti-tumor immunity in naturally occurring hepatitis B virus-related hepatocellular carcinoma in mice Hepatology (IF 17.298) Pub Date : 2022-08-08 Yuwei Wu, Xiaolei Hao, Haiming Wei, Rui Sun, Yongyan Chen, Zhigang Tian
Chronic hepatitis B virus (HBV) infection is the leading cause of hepatocellular carcinoma (HCC) and is a serious health problem in China, East Asia, and North African countries. Effective treatment of HBV-related HCC is currently unavailable. This study evaluated the therapeutic potential of TIGIT blockade in HBV-related HCC.
-
Multi-omics characterization of mouse hepatoblastoma identifies novel YAP1 target genes Hepatology (IF 17.298) Pub Date : 2022-08-06 Tomás C. Rodríguez, SuetYan Kwan, Jordan L. Smith, Sina Dadafarin, Chern-Horng Wu, Erik J. Sontheimer, Wen Xue
Abstract
-
Hepatocyte Ltb4r1 promotes NAFLD development in obesity Hepatology (IF 17.298) Pub Date : 2022-08-05 Xingfeng Liu, Kai Wang, Luhai Wang, Lijuan Kong, Shaocong Hou, Yanjun Wan, Chunxiao Ma, Jingwen Chen, Xiaowei Xing, Caiyi Xing, Qian Jiang, Qijin Zhao, Bing Cui, Zhifeng Huang, Pingping Li
Abstract
-
Enhanced mitochondrial activity reshapes a gut microbiota profile that delays NASH progression Hepatology (IF 17.298) Pub Date : 2022-08-03 María Juárez-Fernández, Naroa Goikoetxea-Usandizaga, David Porras, María Victoria García-Mediavilla, Miren Bravo, Marina Serrano-Maciá, Jorge Simón, Teresa C. Delgado, Sofía Lachiondo-Ortega, Susana Martínez-Flórez, Óscar Lorenzo, Mercedes Rincón, Marta Varela-Rey, Leticia Abecia, Héctor Rodríguez, Juan Anguita, Esther Nistal, María Luz Martínez-Chantar, Sonia Sánchez-Campos
Recent studies suggest that mitochondrial dysfunction promotes progression to non-alcoholic steatohepatitis (NASH) by aggravating the gut-liver status. However, the underlying mechanism remains unclear. Herein, we hypothesized that enhanced mitochondrial activity might reshape a specific microbiota signature that, when transferred to germ-free (GF) mice, could delay NASH progression.
-
Mortality after transjugular intrahepatic portosystemic shunt in older adult cirrhotic patients: a validated prediction model Hepatology (IF 17.298) Pub Date : 2022-08-03 Francesco Vizzutti, Ciro Celsa, Vincenza Calvaruso, Marco Enea, Salvatore Battaglia, Laura Turco, Marco Senzolo, Silvia Nardelli, Roberto Miraglia, Davide Roccarina, Claudia Campani, Dario Saltini, Cristian Caporali, Federica Indulti, Stefano Gitto, Alberto Zanetto, Gabriele Di Maria, Marcello Bianchini, Maddalena Pecchini, Silvia Aspite, Chiara Di Bonaventura, Michele Citone, Tomas Guasconi, Fabrizio
Implantation of a transjugular intrahepatic portosystemic shunt (TIPS) improves survival in cirrhotic patients with refractory ascites and portal hypertensive bleeding. However, the indication for TIPS in older adult patients (≥70 years) is debated and a specific prediction model developed in this particular setting is lacking. The aim of this study was to develop and validate a multivariable model
-
Differential requirement of Hippo cascade during CTNNB1 or AXIN1 mutation driven hepatocarcinogenesis Hepatology (IF 17.298) Pub Date : 2022-08-03 Binyong Liang, Haichuan Wang, Yu Qiao, Xue Wang, Manning Qian, Xinhua Song, Yi Zhou, Yi Zhang, Runze Shang, Li Che, Yifa Chen, Zhiyong Huang, Hong Wu, Satdarshan P. Monga, Yong Zeng, Diego F. Calvisi, Xiaoping Chen, Xin Chen
Gain-of-function (GOF) mutations of CTNNB1 and loss-of-function (LOF) mutations of AXIN1 are recurrent genetic alterations in hepatocellular carcinoma (HCC). We aim to investigate the functional contribution of Hippo/YAP/TAZ in GOF CTNNB1 or LOF AXIN1 mutant HCCs.
-
The NADPH oxidase NOX4 regulates redox and metabolic homeostasis preventing hepatocellular carcinoma progression Hepatology (IF 17.298) Pub Date : 2022-08-03 Irene Peñuelas-Haro, Rut Espinosa-Sotelo, Eva Crosas-Molist, Macarena Herranz-Itúrbide, Daniel Caballero-Díaz, Ania Alay, Xavier Solé, Emilio Ramos, Teresa Serrano, María L. Martínez-Chantar, Ulla G. Knaus, José M. Cuezva, Antonio Zorzano, Esther Bertran, Isabel Fabregat
The NADPH oxidase NOX4 plays a tumor suppressor function in hepatocellular carcinoma (HCC). Silencing NOX4 confers higher proliferative and migratory capacity to HCC cells and increases their in vivo tumorigenic potential in xenografts in mice. NOX4 gene deletions are frequent in HCC, correlating with higher tumor grade and worse recurrence-free and overall survival rates. However, despite of the accumulating
-
Letter to the editor: Disrupted BRCA1-PALB2 interaction induces tumor immunosuppression and T-lymphocyte infiltration in HCC through cGAS-STING pathway. Hepatology (IF 17.298) Pub Date : 2022-08-08 Jun Cao,Dou-Sheng Bai
-
Letter to the editor: Overlooking the important factor: Hypoxia. Hepatology (IF 17.298) Pub Date : 2022-08-03 Yusheng Guo,Yanqiao Ren,Xiangjun Dong,Xuefeng Kan,Chuansheng Zheng
-
Letter to the editor: Cautious interpretation of the compensation of insulin-mTORC1 activation to promote liver regeneration in the absence of hepatocyte β-catenin Hepatology (IF 17.298) Pub Date : 2022-08-02 Cong Ning, Xin-Mu Zhang, Xin-Ting Sang, Hai-Tao Zhao
CONFLICT OF INTEREST Nothing to report.
-
HCC EV ECG Score: An Extracellular Vesicle-based Protein Assay for Detection of Early-Stage Hepatocellular Carcinoma Hepatology (IF 17.298) Pub Date : 2022-07-31 Na Sun, Ceng Zhang, Yi-Te Lee, Benjamin V. Tran, Jing Wang, Hyoyong Kim, Junseok Lee, Ryan Y. Zhang, Jasmine J. Wang, Junhui Hu, Zhicheng Zhang, Manaf S. Alsudaney, Kuan-Chu Hou, Hubert Tang, Tiffany X. Zhang, Icy Y. Liang, Ziang Zhou, Mengxiang Chen, Angela Hsiao-Jiun Yeh, Wenyuan Li, Xianghong Jasmine Zhou, Helena R. Chang, Steven-Huy B. Han, Saeed Sadeghi, Richard S. Finn, Sammy Saab, Ronald W.
Abstract
-
Reply Hepatology (IF 17.298) Pub Date : 2022-07-28 Hui Ma, Bing Xia
CONFLICT OF INTEREST Nothing to report.
-
Direct chemical induction of hepatocyte-like cells with capacity for liver repopulation Hepatology (IF 17.298) Pub Date : 2022-07-26 Yunfei Bai, Zhenghao Yang, Xiaochan Xu, Wanqiu Ding, Juntian Qi, Feng Liu, Xiaoxiao Wang, Bin Zhou, Wenpeng Zhang, Xiaomei Zhuang, Guanglu Li, Yang Zhao
Cell fate can be directly reprogrammed from accessible cell types (e.g., fibroblasts) into functional cell types by exposure to small molecule stimuli. However, no chemical reprogramming method has been reported to date that successfully generates functional hepatocyte-like cells that can repopulate liver tissue, casting doubt over the feasibility of chemical reprogramming approaches to obtain desirable
-
AASLD Practice Guidance on Drug, Herbal and Dietary Supplement Induced Liver Injury. Hepatology (IF 17.298) Pub Date : 2022-07-27 Robert J Fontana,Iris Liou,Adrian Reuben,Ayako Suzuki,Isabel Fiel,William Lee,Victor Navarro
-
Letter to the Editor: Successful treatment of multidrug resistant hepatitis C after >12 months of continuous therapy with direct-acting antivirals Hepatology (IF 17.298) Pub Date : 2022-07-27 Sheri Trudeau, Vivek Mendiratta, Yara Dababneh, Jennifer Hollingsworth, Stuart C. Gordon
CONFLICT OF INTEREST Nothing to report.
-
Letter to the editor: County-level variation in hepatitis C virus mortality and trends in the United States, 2005-2017. Hepatology (IF 17.298) Pub Date : 2022-07-26 Muhammad Shehryar,Muhammad Zawar Asif,Muhammad Umair
-
How many steps to a feasible mouse model of hepatitis B virus infection? Hepatology (IF 17.298) Pub Date : 2022-07-24 Michael Nassal
-
Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPS Hepatology (IF 17.298) Pub Date : 2022-07-23 Alexander Queck, Louise Schwierz, Wenyi Gu, Philip G. Ferstl, Christian Jansen, Frank E. Uschner, Michael Praktiknjo, Johannes Chang, Maximilian J. Brol, Filippo Schepis, Manuela Merli, Christian P. Strassburg, Jennifer Lehmann, Carsten Meyer, Jonel Trebicka
-
Hepatocyte β-Catenin Loss is Compensated by Insulin-mTORC1 Activation to Promote Liver Regeneration Hepatology (IF 17.298) Pub Date : 2022-07-21 Shikai Hu, Catherine Cao, Minakshi Poddar, Evan Delgado, Sucha Singh, Anya Singh-Varma, Donna Beer Stolz, Aaron Bell, Satdarshan P. Monga
Abstract
-
Letter to the editor: Reflection on the no-association between the presence of fatty liver disease and mortality in the elderly. Hepatology (IF 17.298) Pub Date : 2022-07-21 Cong Ning,Shi-Tao Jiang,Xin-Ting Sang
-
Reply Letter for 20-3104.R2-The significant difference between East Asian and Western non- drinkers. Hepatology (IF 17.298) Pub Date : 2022-07-21 Kwang Yoon Kim,Kyung-Won Hong,Bom Taeck Kim
-
Letter to the editor: NAFLD and sarcopenia: Association or causation? Hepatology (IF 17.298) Pub Date : 2022-07-21 Junwei Zhang,Yiyao Xu,Xin Lu,Haitao Zhao
-
Reply: NAFLD and sarcopenia: Association or causation? Hepatology (IF 17.298) Pub Date : 2022-07-21 Dong Hyun Sinn, Danbee Kang, Eliseo Guallar, Juhee Cho, Geum-Youn Gwak
CONFLICT OF INTEREST Nothing to report.
-
Reply Hepatology (IF 17.298) Pub Date : 2022-07-21 Laurens A. van Kleef, Milan J. Sonneveld, Robert J. de Knegt
CONFLICTS OF INTEREST Milan J. Sonneveld is on the speakers' bureau and received grants from Fujirebio. He received grants from Gilead. Robert J. de Knegt consults for and received grants from AbbVie. He is on the speakers’ bureau for Echosens. He received grants from Gilead and Janssen.
-
Acute hepatitis of unknown origin in children: Behind the statistics Hepatology (IF 17.298) Pub Date : 2022-07-21 Randa Elsheikh, Hoang Thuy Tien, Abdelrahman M. Makram, Nguyen Thanh Van, Trang Thi Bich Le, Tamilarasy Vasanthakumaran, Nguyen Tien Huy
-
Reply Hepatology (IF 17.298) Pub Date : 2022-07-20 Margarita Papatheodoridi, Anna S. Lok, George V. Papatheodoridis
CONFLICT OF INTEREST M. Papatheodoridi: none; A.S. Lok: research grants from Bristol-Myers Squibb, Gilead, and TARGET; G.V. Papatheodoiridis: advisor/lecturer for Amgen, Gilead, GlaxoSmithKline, Ipsen, Janssen, Novo Nordisk, Roche, and Takeda and research grants from Gilead.
-
Hepatocyte-derived MASP1-enriched small extracellular vesicles activate HSCs to promote liver fibrosis Hepatology (IF 17.298) Pub Date : 2022-07-18 Xianzhi Liu, Siwei Tan, Huiling Liu, Jie Jiang, Xing Wang, Leijia Li, Bin Wu
-
Adipose lipolysis is important for ethanol to induce fatty liver in the National Institute on Alcohol Abuse and Alcoholism murine model of chronic and binge ethanol feeding Hepatology (IF 17.298) Pub Date : 2022-07-18 Mallika Mathur, Yu-Te Yeh, Rakesh K. Arya, Long Jiang, Majid Pornour, Weiping Chen, Yinyan Ma, Bin Gao, Ling He, Zhekang Ying, Bingzhong Xue, Hang Shi, Youngshim Choi, Liqing Yu
-
Letter to the editor: Aspirin use and the risk of hepatocellular carcinoma. Hepatology (IF 17.298) Pub Date : 2022-07-17 Shih-Wei Lai
-
Letter to the Editor: Hepatitis B virus reactivation in immune checkpoint inhibitor-based combination therapies for hepatocellular carcinoma. Hepatology (IF 17.298) Pub Date : 2022-07-15 Zhi-Cheng Jin,Jian-Jian Chen,Biao Luo,Wei-Hua Zhang,Gao-Jun Teng
-
Inhibition of mPGES-2 ameliorates NASH by activating NR1D1 via heme Hepatology (IF 17.298) Pub Date : 2022-07-15 Dandan Zhong, Jie Cai, Cheng Hu, Jingshuo Chen, Rumeng Zhang, Chenyu Fan, Shanshan Li, Hongxing Zhang, Zhou Xu, Zhanjun Jia, Dong Guo, Ying Sun
-
Letter to the editor: Change in serial liver stiffness measurement by magnetic resonance elastography and outcomes in NAFLD. Hepatology (IF 17.298) Pub Date : 2022-07-14 Georg Semmler,Katrine Holtz Thorhauge,Thomas Reiberger,Maja Thiele
-
Reply: Change in serial liver stiffness measurement by MR elastography and outcomes in NAFLD Hepatology (IF 17.298) Pub Date : 2022-07-14 Tolga Gidener, Ross Dierkhising, Kristin C. Mara, Terry M. Therneau, Sudhakar K. Venkatesh, Richard L. Ehman, Meng Yin, Alina M. Allen
CONFLICT OF INTEREST Richard L. Ehman has intellectual property rights and a financial interest in magnetic resonance elastography. He serves as uncompensated CEO of Resoundant, Inc., a Mayo Clinic company. Meng Yen owns stock in Resoundant. She has intellectual property rights and a financial interest in magnetic resonance elastography. The Mayo Clinic has intellectual property rights and a financial
-
COVID-19-associated cholangiopathy: What is left after the virus has gone? Hepatology (IF 17.298) Pub Date : 2022-07-13 Niklas Heucke, Verena Keitel
While the respiratory tract represents the primary target of severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) infection, it has become evident that COVID-19 is a multisystemic infectious disease. The hepatobiliary system could be affected during infection, ranging from slightly elevated liver enzymes to liver failure or secondary sclerosing cholangitis (SSC). Whether direct cytopathic
-
Validation of the new 2021 EASL algorithm for the noninvasive diagnosis of advanced fibrosis in NAFLD Hepatology (IF 17.298) Pub Date : 2022-07-13 Clémence M. Canivet, Charlotte Costentin, Katharina M. Irvine, Adèle Delamarre, Adrien Lannes, Nathalie Sturm, Frederic Oberti, Preya J. Patel, Thomas Decaens, Marie Irles-Depé, Isabelle Fouchard, Paul Hermabessière, Marine Roux, Justine Barthelon, Paul Calès, Elizabeth E. Powell, Victor de Ledinghen, Jérôme Boursier
-
In vivo imaging of calcium dynamics in zebrafish hepatocytes Hepatology (IF 17.298) Pub Date : 2022-07-13 Macarena Pozo-Morales, Inés Garteizgogeascoa, Camille Perazzolo, Juhoon So, Donghun Shin, Sumeet Pal Singh
-
Reply Hepatology (IF 17.298) Pub Date : 2022-07-12 Lukas Hartl, Thomas Reiberger, Michael Trauner
We thank Jiang et al.[1] for the interest in our study on progressive cholestasis and secondary sclerosing cholangitis (SSC) after coronavirus disease 2019 (COVID-19) in patients with chronic liver disease (CLD)[2] that has raised clinical awareness for long-term hepatobiliary complications of COVID-19. Importantly, patients with CLD, especially NAFLD/NASH, and those with severe courses of COVID-19
-
Letter to the editor: Complications following SARS-CoV-2 infection in patients with chronic liver disease Hepatology (IF 17.298) Pub Date : 2022-07-12 Shi-Tao Jiang, Lei Zhang, Yi-Yao Xu, Xin Lu
To the editor, Recently, Hartl et al. reported a study on liver-related complications after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.[1] This single-center retrospective study includes 65 patients with NAFLD/NASH-predominant chronic liver disease (CLD). They described the pattern of progression of cholestatic liver injury following SARS-CoV-2 infection. Hartl et al. noted
-
Next-generation pathology detection of T cell–antigen-presenting cell immune synapses in human liver allografts Hepatology (IF 17.298) Pub Date : 2022-07-12 Michelle A. Wood-Trageser, Drew Lesniak, Alessandro Gambella, Kayla Golnoski, Sandy Feng, John Bucuvalas, Alberto Sanchez-Fueyo, A. Jake Demetris
-
Letter to the editor: Several issues to consider in the study of hepatocellular carcinoma progression mechanism. Hepatology (IF 17.298) Pub Date : 2022-07-11 Fan Yang,Shi-Tao Jiang,Xin Lu,Yiyao Xu,Yong-Chang Zheng
-
NAD+ salvage governs mitochondrial metabolism, invigorating natural killer cell antitumor immunity Hepatology (IF 17.298) Pub Date : 2022-07-11 Xiaowei Guo, Siyu Tan, Tixiao Wang, Renhui Sun, Shuangjie Li, Panpan Tian, Mengzhen Li, Yuzhen Wang, Yankun Zhang, Yuchuan Yan, Zhaoru Dong, Lunjie Yan, Xuetian Yue, Zhuanchang Wu, Chunyang Li, Kazuya Yamagata, Lifen Gao, Chunhong Ma, Tao Li, Xiaohong Liang
-
Letter to the Editor: The limited function of most circRNAs as a microRNA sponge. Hepatology (IF 17.298) Pub Date : 2022-07-10 Ye-Zhao Wang
-
Reply to: The limited function of most circRNAs as a microRNA sponge. Hepatology (IF 17.298) Pub Date : 2022-07-10 Hui Li,Chang Liu,Hong Wu
-
-
Sociodemographic and georaphic differences in the US epidemiology of autoimmune hepatitis with and without cirrhosis Hepatology (IF 17.298) Pub Date : 2022-07-10 Therese Bittermann, James D. Lewis, Cynthia Levy, David S. Goldberg
-
Reply Hepatology (IF 17.298) Pub Date : 2022-07-09 Vladimir Loukachov, Karel van Dort, Robin Erken, Henk W. Reesink, Neeltje Kootstra
CONFLICT OF INTEREST Nothing to report.
-
Machine learning models are superior to noninvasive tests in identifying clinically significant stages of NAFLD and NAFLD-related cirrhosis Hepatology (IF 17.298) Pub Date : 2022-07-09 Devon Chang, Emily Truong, Edward A. Mena, Fabiana Pacheco, Micaela Wong, Maha Guindi, Tsuyoshi T. Todo, Nabil Noureddin, Walid Ayoub, Ju Dong Yang, Irene K. Kim, Anita Kohli, Naim Alkhouri, Stephen Harrison, Mazen Noureddin
-
Less is more? Screening for steatosis in older populations. Hepatology (IF 17.298) Pub Date : 2022-07-08 Hannes Hagström,Ying Shang
-
Letter to the Editor: Low sensitivity of RT-Alu-PCR in detection of HBV integrated chimeric transcripts. Hepatology (IF 17.298) Pub Date : 2022-07-08 Abudurexiti Abulaiti,Zhiqiang Gu,Qianqian Jiang,Hongxin Huang,Fengmin Lu
-
RNA helicase DEAD-box protein 5 alleviates nonalcoholic steatohepatitis progression via tethering TSC complex and suppressing mTORC1 signaling Hepatology (IF 17.298) Pub Date : 2022-07-07 Yanqiu Zhang, Shengtao Ye, Weijia Lu, Jiawen Zhong, Yingrong Leng, Ting Yang, Jun Luo, Wenjun Xu, Hao Zhang, Lingyi Kong
-
Letter to the editor: l-ornithine l-aspartate in acute treatment of severe hepatic encephalopathy: A double-blind randomized controlled trial. Hepatology (IF 17.298) Pub Date : 2022-07-05 Alexander J Kovalic,Tai-Ping Lee,Ben L Da
-
Age and the relative importance of liver-related deaths in nonalcoholic fatty liver disease Hepatology (IF 17.298) Pub Date : 2022-07-05 Huapeng Lin, Terry Cheuk-Fung Yip, Xinrong Zhang, Guanlin Li, Yee-Kit Tse, Vicki Wing-Ki Hui, Lilian Yan Liang, Jimmy Che-To Lai, Stephen Lam Chan, Henry Lik-Yuen Chan, Grace Lai-Hung Wong, Vincent Wai-Sun Wong
-
Essential lipid autacoids rewire mitochondrial energy efficiency in metabolic dysfunction-associated fatty liver disease Hepatology (IF 17.298) Pub Date : 2022-07-05 Cristina López-Vicario, David Sebastián, Mireia Casulleras, Marta Duran-Güell, Roger Flores-Costa, Ferran Aguilar, Juan José Lozano, Ingrid W. Zhang, Esther Titos, Jing X. Kang, Antonio Zorzano, Makoto Arita, Joan Clària